Spebrutinib besylate
CAS: 1360053-81-1
Ref. 3D-KEC05381
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
Spebrutinib besylate is a salt form of spebrutinib, which is a small molecule tyrosine kinase inhibitor. It has been shown to inhibit the proliferation of lymphocytes in vitro and in vivo. The mechanism by which spebrutinib besylate inhibits cell proliferation is not fully understood, but it may be due to inhibition of tyrosine kinases and their downstream signaling pathways. Spebrutinib besylate also has potential antineoplastic activity, as it targets family members that are involved in the development and progression of lymphoma.
Propiedades químicas
Consulta técnica sobre: 3D-KEC05381 Spebrutinib besylate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
